In conclusion, our study revealed that CA-IX expression is an important molecular predictor for postoperative tumor recurrence, and thus a prognostic indicator of unfavorable outcome, and can be a potential therapeutic target for HCC. The gene discussed is CA9; the disease is hepatocellular carcinoma.